Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.
2.

von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.

Lehrer S, Rheinstein PH, Green S, Rosenzweig KE.

Brain Tumor Res Treat. 2019 Apr;7(1):33-38. doi: 10.14791/btrt.2019.7.e20.

3.

Increased RNA Expression of von Willebrand Factor Gene Is Associated With Infiltrating Lobular Breast Cancer and Normal PAM50 Subtype.

Lehrer S, Green S, Dembitzer FR, Rheinstein PH, Rosenzweig KE.

Cancer Genomics Proteomics. 2019 May-Jun;16(3):147-153. doi: 10.21873/cgp.20120.

PMID:
31018945
4.

Mouse mammary tumor viral env sequences are not present in the human genome but are present in breast tumors and normal breast tissues.

Lehrer S, Rheinstein PH.

Virus Res. 2019 Jun;266:43-47. doi: 10.1016/j.virusres.2019.03.011. Epub 2019 Apr 3.

PMID:
30951792
6.

Allergy may confer better survival on patients with gliomas.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Clin Neurol Neurosurg. 2019 Feb;177:63-67. doi: 10.1016/j.clineuro.2018.12.021. Epub 2018 Dec 31.

7.

Three Poliovirus Sequences in the Human Genome Associated With Colorectal Cancer.

Lehrer S, Rheinstein PH.

Cancer Genomics Proteomics. 2019 Jan-Feb;16(1):65-70. doi: 10.21873/cgp.20112.

8.

No Relationship of Anti-Androgens to Alzheimer's Disease or Cognitive Disorder in the MedWatch Database.

Lehrer S, Rheinstein PH, Rosenzweig KE.

J Alzheimers Dis Rep. 2018 Jun 30;2(1):123-127. doi: 10.3233/ADR-180052.

9.

Inverse Relationship Between Polio Incidence in the US and Colorectal Cancer.

Lehrer S, Rheinstein PH.

In Vivo. 2018 Nov-Dec;32(6):1485-1489. doi: 10.21873/invivo.11404.

10.

Increased expression of von Willebrand factor gene is associated with poorer survival in primary lower grade glioma.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Glioma. 2018 Jul-Aug;1(4):132-135. doi: 10.4103/glioma.glioma_17_18. Epub 2018 Aug 30.

11.

Expression of the Vesicular Monoamine Transporter Gene Solute Carrier Family 18 Member 1 (SLC18A1) in Lung Cancer.

Lehrer S, Rheinstein PH.

Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):387-393. doi: 10.21873/cgp.20097.

12.

Alzheimer's Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database.

Lehrer S, Rheinstein PH.

J Alzheimers Dis Rep. 2018;2(1):111-115. doi: 10.3233/ADR-170033. Epub 2018 Jun 29.

13.

Loss of MycBP may be associated with the improved survival in 1P co-deletion of lower grade glioma patients.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Clin Neurol Neurosurg. 2018 Sep;172:112-115. doi: 10.1016/j.clineuro.2018.07.003. Epub 2018 Jul 5.

PMID:
29986195
14.

Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the SGK1 Gene Are Associated with Poorer Survival.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):273-278. doi: 10.21873/cgp.20085.

15.

In primary glioblastoma fewer tumor copy number segments of the F13A1 gene are associated with poorer survival.

Lehrer S, Dembitzer FR, Rheinstein PH, Rosenzweig KE.

Thromb Res. 2018 Jul;167:12-14. doi: 10.1016/j.thromres.2018.05.001. Epub 2018 May 4. No abstract available.

PMID:
29753279
16.

Mutations of the PDE5A Gene Confer a Survival Advantage in Patients with Colon Cancer.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer Prev Res (Phila). 2018 Jul;11(7):439-440. doi: 10.1158/1940-6207.CAPR-18-0105. Epub 2018 May 3. No abstract available.

PMID:
29724712
17.

Periodontal Disease and Incident Cancer-Letter.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer Epidemiol Biomarkers Prev. 2018 May;27(5):614-615. doi: 10.1158/1055-9965.EPI-17-0726. No abstract available.

18.

Improving the survival of patients with American Joint Committee on Cancer stage III and IV melanoma.

Lehrer S, Rheinstein PH, Rosenzweig KE.

Cancer. 2018 May 15;124(10):2253. doi: 10.1002/cncr.31262. Epub 2018 Mar 15. No abstract available.

19.

Nasal steroids as a possible treatment for Alzheimer's disease.

Lehrer S, Rheinstein PH.

Discov Med. 2017 Oct;24(132):147-152. Review.

20.

Association of Radon Background and Total Background Ionizing Radiation with Alzheimer's Disease Deaths in U.S. States.

Lehrer S, Rheinstein PH, Rosenzweig KE.

J Alzheimers Dis. 2017;59(2):737-741. doi: 10.3233/JAD-170308.

PMID:
28671130
21.
22.
23.

Is Alzheimer's Disease Autoimmune Inflammation of the Brain That Can be Treated With Nasal Nonsteroidal Anti-Inflammatory Drugs?

Lehrer S, Rheinstein PH.

Am J Alzheimers Dis Other Demen. 2015 May;30(3):225-7. doi: 10.1177/1533317514545478. Epub 2014 Aug 5.

PMID:
25100747
24.

Editor's Note.

Yang B, Rheinstein PH.

Discov Med. 2005 Apr;5(26):120. No abstract available.

25.

Overview of the US Food and Drug Administration's reform legislation.

Rheinstein PH.

Clin Ther. 1998;20 Suppl C:C4-11. Review.

PMID:
9915084
26.

Keeping abreast of new drug approvals and labeling changes.

Rheinstein PH, Tsai VW.

Am Fam Physician. 1998 Sep 15;58(4):995-8. No abstract available.

27.

Significant FDA approvals in 1997.

Rheinstein PH, Akbari B.

Am Fam Physician. 1998 Jun;57(11):2865-8. No abstract available.

28.

Prescription to over-the-counter drug switches.

Rheinstein PH.

Am Fam Physician. 1997 Sep 15;56(4):1211-4. No abstract available.

PMID:
9310067
29.

Significant FDA approvals in 1996.

Rheinstein PH.

Am Fam Physician. 1997 Jun;55(8):2855-8. No abstract available.

PMID:
9191461
30.

Children and tobacco: the FDA's final rule.

Rheinstein PH, McGinnis TJ, Nightingale SL.

Am Fam Physician. 1997 Mar;55(4):1441-4. Review. No abstract available.

PMID:
9092294
31.

Seven tips for sun sense.

Rheinstein PH.

Am Fam Physician. 1996 Sep 15;54(4):1385-8. No abstract available.

PMID:
8816578
32.

Ways to access FDA information.

Rheinstein PH, McGinnis TJ.

Am Fam Physician. 1996 Jul;54(1):353-8. No abstract available.

PMID:
8677842
33.

Significant FDA approvals in 1995.

Rheinstein PH.

Am Fam Physician. 1996 Apr;53(5):1871-4. No abstract available.

PMID:
8623703
34.

The patient information and education initiative.

Rheinstein PH, McGinnis TJ, Nightingale SL.

Am Fam Physician. 1995 Dec;52(8):2377-8, 2381-2. No abstract available.

PMID:
7484726
35.

Children and tobacco: the Clinton administration proposal.

Rheinstein PH, McGinnis TJ.

Am Fam Physician. 1995 Sep 15;52(4):1205-8. No abstract available.

PMID:
7668208
36.

Home test kits and monitors.

Rheinstein PH, Thomas A.

Am Fam Physician. 1995 Jul;52(1):293-6. Review. No abstract available.

PMID:
7604768
37.

Significant FDA approvals in 1994.

Rheinstein PH.

Am Fam Physician. 1995 Mar;51(4):888-90. No abstract available.

PMID:
7887364
38.

Avoiding problems with liquid medications and dosing devices.

Rheinstein PH.

Am Fam Physician. 1994 Dec;50(8):1771-2. No abstract available.

PMID:
7619108
39.

Access to investigational drugs for treatment purposes.

Nightingale SL, Kimbrough CA, Rheinstein PH.

Am Fam Physician. 1994 Sep 15;50(4):845-7. No abstract available.

PMID:
8079913
40.

The Mammography Quality Standards Act of 1992.

Hoffman FA, Rheinstein PH, Houn F.

Am Fam Physician. 1994 Jun;49(8):1965-70. No abstract available.

PMID:
8203325
41.

The generic drug approval process.

Rheinstein PH.

Am Fam Physician. 1993 Dec;48(8):1357-60. No abstract available.

PMID:
8249762
42.

MedWatch: the FDA medical products reporting program.

Rheinstein PH.

Am Fam Physician. 1993 Sep 15;48(4):636-8. No abstract available.

PMID:
8379493
43.

Shellfish-borne illnesses.

Rheinstein PH, Klontz KC.

Am Fam Physician. 1993 Jun;47(8):1837-40. Review. No abstract available.

PMID:
8498290
44.

Update on food labeling.

Rheinstein PH.

Am Fam Physician. 1993 Mar;47(4):979-82. No abstract available.

PMID:
8438688
45.

Healthy people 2000 initiative.

Rheinstein PH.

Am Fam Physician. 1992 Dec;46(6):1829-32. No abstract available.

PMID:
1456200
46.

Reporting of adverse drug events: a key to postmarketing drug safety.

Rheinstein PH.

Am Fam Physician. 1992 Sep;46(3):873-4. No abstract available.

PMID:
1514478
47.

Drug company sponsorship of education: the response to the FDA draft concept paper.

Lazar EJ, Banks D, Graham C, Adams D, Rheinstein PH, Gross M, Witt AM.

JAMA. 1992 Jul 1;268(1):53-4. No abstract available.

PMID:
1608109
48.

Medication errors.

Rheinstein PH, McGinnis TJ.

Am Fam Physician. 1992 Jun;45(6):2720-2. No abstract available.

PMID:
1595519
49.

Food labeling reforms for 1992.

Rheinstein PH, Bagley GP.

Am Fam Physician. 1992 Mar;45(3):1349-53. No abstract available.

PMID:
1543114
50.

Update on breast implants.

Rheinstein PH, Bagley GP.

Am Fam Physician. 1992 Feb;45(2):472-3. No abstract available.

PMID:
1739038

Supplemental Content

Loading ...
Support Center